About Orum Therapeutics Orum Therapeutics is a private, clinical-stage biotech pioneering the development of tumor-directed targeted protein degraders by leveraging its TPD² approach to provide ...

Orum Therapeutics Submits Registration Statement for KOSDAQ Listing Initial public offering price range of KRW 30,000 to KRW 36,000 October 02, 2024 09:26 AM Eastern Daylight Time ...

Orum to receive a $15 million upfront payment and up to $310 million in potential option fees and milestone payments per target plus tiered royalties. BOSTON& DAEJEON, South Korea---- Orum ...